Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. medical centers in 2010-2011

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1982-1988

  Sader, Helio S ^a   Flamm, Robert K ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIBACTAM; CEFTAROLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BROTH DILUTION; ENTEROBACTER CLOACAE; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; AZABICYCLO COMPOUNDS; CEPHALOSPORINS; DRUG COMBINATIONS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE;

EID: 84875140013     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02436-12     Document Type: Article

References (14)

1. File TM, Jr, WilcoxMH,Stein GE. 2012. Summary of ceftaroline fosamil clinical trial studies and clinical safety Clin. Infect. Dis. 55(Suppl 3):S173-S180.
2. Flamm RK, Sader HS, Farrell DJ, Jones RN. 2012. Summary of ceftaroline activity against pathogens in the United States, 2010: report from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program. Antimicrob. Agents Chemother. 56:2933-2940.
3. Castanheira M, Sader HS, Farrell DJ, Mendes RE, Jones RN. 2012. Activity of ceftaroline-avibactam tested against Gram-negative organism populations, including strains expressing one or more beta-lactamases and methicillin-resistant Staphylococcus aureus carrying various SCCmec types. Antimicrob. Agents Chemother. 56:4779-4785.
4. AstraZeneca AB. 2012. Zinforo package insert. AstraZeneca AB, Södertälje, Sweden. http://www.ema.europa.eu/docs/en-GB/document- library/EPAR-Product-Information/human/002252/WC500132586.pdf. Accessed December 2012.
5. Ehmann DE, Jahic H, Ross PL, Gu RF, Hu J, Kern G, Walkup GK, Fisher SL. 2012. Avibactam is a covalent, reversible, non-beta-lactam beta-lactamase inhibitor. Proc. Natl. Acad. Sci. U. S. A. 109:11663-11668.
6. Clinical and Laboratory Standards Institute. 2012. M07-A9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard: 9th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2013. M100-S23. Performance standards for antimicrobial susceptibility testing: 23rd informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2010. M45-A2. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria: 2nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
9. EUCAST. January 2013. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0. ESCMID, Basel, Switzerland. http://www.eucast.org/ clinical-breakpoints/. Accessed 2 January 2013.
10. Forest Pharmaceuticals, Inc. 2012. Teflaro package insert. Forest Pharmaceuticals, Inc., St. Louis, MO. http://www.frx.com/pi/Teflaro-pi.pdf. Accessed September 2012.
11. Pfizer. 2011. Tygacil package insert. Pfizer, New York, NY. www.tygacil.com. Accessed September 2012.
12. Kanj SS, Kanafani ZA. 2011. Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum betalactamase- producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin. Proc. 86:250 -259.
13. Castanheira M, Mendes RE, Woosley LN, Jones RN. 2011. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY Antimicrobial Surveillance Programme (2007-09). J. Antimicrob. Chemother. 66:1409 -1411.
14. Mushtaq S, Warner M, Williams G, Critchley I, Livermore DM. 2010. Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 65:1428 -1432.